Readit News logoReadit News
_ihaque commented on The Bootstrap Load   intel4004.com/btstrp.htm... · Posted by u/gone35
_ihaque · a month ago
The linked article doesn't say that much about what the bootstrap load is or how it worked, but luckily for us @kens wrote a whole article about it: https://www.righto.com/2020/10/how-bootstrap-load-made-histo...
_ihaque commented on Researchers find a way to make the HIV virus visible within white blood cells   theguardian.com/global-de... · Posted by u/colinprince
SoftTalker · 3 months ago
At some point, Eli Lilly or Pfizer or Astra-Zenica or a company like them will have to mass produce and market the drug. They aren't going to kill their golden geese.
_ihaque · 3 months ago
If this (or, more accurately, a drug developed downstream of this technology) worked, they absolutely would.

A great example of this in relatively recent history is the treatment of hepatitis C. The treatments pre-circa-2011 were pretty crappy: interferon/ribavirin had poor cure rates and bad side effects. But it was still better than hepatitis destroying your liver, so people dealt with it.

Then, in 2011, as the culmination of years of trials, telaprevir (from Vertex/J&J) [1] and boceprevir (Schering-Plough/Merck) [2] were approved and were DRAMATICALLY BETTER than interferon/ribavirin.

...and then just two years later both of these drugs got nuked by the approval of sofosbuvir (aka Sovaldi, from Pharmasset/Gilead) [3], which has _cure_ rates in excess of 90%. Telaprevir and boceprevir were pulled from the market because there was simply no more market for them once sofosbuvir hit. Scientific competition at its finest.

There is absolutely a dark side to pharmaceutical pricing and licensing, but please don't let the existence of that dark side cloud your vision of the transformative impact that those of us in biotech R&D want to have (and in many cases, have had). I was at Vertex when the early trial data on telaprevir started coming out and it became clear that we might be able to offer patients real hope who did not have it before.

[1] https://en.wikipedia.org/wiki/Telaprevir [2] https://en.wikipedia.org/wiki/Boceprevir [3] https://en.wikipedia.org/wiki/Sofosbuvir

_ihaque commented on A toy RTOS inside Super Mario Bros. using emulator save states   prettygoodblog.com/p/what... · Posted by u/notorious_pgb
ranger207 · 3 months ago
Hyperthreading is Intel's implementation of SMP
_ihaque · 3 months ago
I think you mean SMT (simultaneous multithreading), as opposed to SMP (symmetric multiprocessing)?
_ihaque commented on Eli Lilly will soon release key data on its weight loss pill orforglipron   cnbc.com/2025/03/24/eli-l... · Posted by u/toomuchtodo
_ihaque · 6 months ago
Those wondering about the mouthful of a name that is "orforglipron" may be interested in the INN (international nonproprietary name) standard for generic drugs. That name is a "generic" or "nonproprietary" name.

Those typically have a "stem" which indicate the mechanism by which the drug works. In this case, it's "-glipron", which you can parse as "glipr" -- GLP-1 receptor -- and "on" -- it's an "agonist", or something that turns "on" the receptor. So "-glipron"s are drugs which agonize, or activate, the GLP-1 receptor. There are other gliprons in trials, including danuglipron (https://en.wikipedia.org/wiki/Danuglipron) from Pfizer, and many others that don't have assigned INNs.

Semaglutide and liraglutide also agonize GLP-1, so why aren't they gliprons? Because chemically they are analogs of the naturally occurring GLP-1 peptide, so they get the -glutide (GLUcagon-like pepTIDE) stem.

I don't know why tirzepatide got that name. It's a peptide, so "-tide" makes sense, but it's actually listed as a "various" exception in the master document of INNs: https://iris.who.int/bitstream/handle/10665/379226/978924009....

_ihaque commented on Eli Lilly will soon release key data on its weight loss pill orforglipron   cnbc.com/2025/03/24/eli-l... · Posted by u/toomuchtodo
loeg · 6 months ago
This isn't just an oral formulation of tirzepatide, right? The article sort of hints at this but doesn't really come out and say it one way or the other.

> Eli Lilly’s pill works in a similar way to Wegovy, Ozempic, and Novo Nordisk’s diabetes pill Rybelsus, targeting a gut hormone called GLP-1 to suppress a person’s appetite and regulate blood sugar.

(These three are all just different names for Semaglutide.)

> But unlike those three medications, Eli Lilly’s pill is not a peptide medication.

> ...

> But so-called small molecule pills [orforglipron] will at least be easier for Eli Lilly to manufacture than injections.

_ihaque · 6 months ago
No, it's not a reformulation of tirzepatide. Orforglipron is a small molecule with a molecular mass of 883 g/mol and tirzepatide is a large molecule peptide six tims larger, with a molecular mass of 4813 g/mol.

The Wikipedia pages are decent -- the picture makes it fairly obvious how much smaller orforglipron is than tirzepatide even if you don't know how to read chemical structures; just count atoms!

https://en.wikipedia.org/wiki/Orforglipron

https://en.wikipedia.org/wiki/Tirzepatide

_ihaque commented on Why Recursion Pharmaceuticals abandoned cell painting for brightfield imaging   owlposting.com/p/why-recu... · Posted by u/abhishaike
ldsldslds · 9 months ago
they dont respond to cold apps in my experience, except canned rejection after a few months for some reason
_ihaque · 9 months ago
We definitely do (as in, I myself have) hire folks from "cold" inbound applications.
_ihaque commented on Why Recursion Pharmaceuticals abandoned cell painting for brightfield imaging   owlposting.com/p/why-recu... · Posted by u/abhishaike
selimthegrim · 9 months ago
Do you guys have a cooldown period for applications?
_ihaque · 9 months ago
Not that I know of! Note that the positions we list are typically in different teams so it's worth reading the descriptions to make sure you're picking whichever one is most appropriate to your experience+interests (and, as a corollary, if you weren't a fit for a previous position, you may be one for one that comes up in the future).

u/_ihaque

KarmaCake day677January 21, 2013
About
CTO at Kimia Therapeutics: https://kimiatx.com

https://bsky.app/profile/ihaque.bsky.social

https://twitter.com/imranshaque

https://ihaque.org

View Original